首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Medical Oncology

Medical Oncology杂志,由Springer US出版,于1984年创刊,Quarterly,出版语言English,ISSN:1357-0560,E-ISSN:1559-131X。

投稿咨询
Medical Oncology
Medical Oncology
Medical Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.7
CiteScore
5.9
期刊收录
SCI、SCIE

Medical Oncology(中文译名:《医学肿瘤学》),ISSN:1357-0560,EISSN:1559-131X,是Springer US出版的国际性学术期刊,创刊于1984年,以Quarterly形式稳定发行,2026年总发文量约596篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.7,2025年期刊CiteScore为5.9,2025年期刊自引率约4.3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Medical Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1.4月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyCHINA MAINLAND、Japan、USA、Poland、India、Brazil等为核心发文国家与地区;UNIVERSITY OF MILANIRCCS EUROPEAN INSTITUTE OF ONCOLOGY (IEO)、SAN PAOLO-POLO UNIVERSITARIA HOSPITAL、IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO、UNIVERSITY OF CALGARY、HIROSAKI UNIVERSITY、JOHNS HOPKINS UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 97 / 333

71

学科:ONCOLOGY SCIE Q2 144 / 333

56.91

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 106 / 328

67.8

学科:ONCOLOGY SCIE Q2 146 / 328

55.64


中国学者近期发文

1
Exploration of the mechanism by which Ubiquitin-like protein UBD promotes malignant progression of breast cance

Author:Ma, Lei; Xie, Bei; Zhang, Rongzhi; Deng, Haohua; Tang, Baoyuan; Zhu, Jinmei; Zhang, Ziqing; Ma, Xingyuan; Wang, Shuaiyang; Li, Linjing

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 6, pp. -. DOI: 10.1007/s12032-025-03168-4

2
Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathwa

Author:Nie, Juan; Jiang, Hequn; Zhou, Runyu; Gong, Ruichen; Xu, Wenli; Zhang, Ping; Lu, Ling; Lyu, Lin

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03293-8

3
RETRACTION: The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cance

Author:He, Tian-Lin; Zhang, Yi-Jie; Jiang, Hui; Li, Xiao-hui; Zhu, Hai; Zheng, Kai-Lian

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03296-5

4
A novel matrine derivative exerts antitumor effects against hepatocellular carcinoma by inducing oxidative stress and DNA damag

Author:Hu, Zhouxing; Wang, Xingdong; Xu, Tingguo; Ou, Anqi; Song, Yuanbo; Wang, Lisheng

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03243-4

5
Research progress and clinical translation challenges in the use of oncolytic bacteria for cancer therap

Author:Lu, Min; Sun, Zhimin; Qian, Yimin; Guo, Jingxu; Liang, Yaping; Han, Kexin; Yan, Weiyuan; Gao, Yaxin; Wang, Kou; Jiang, Minjie; Liu, Yueling; Yang, Bin; Wang, Yan; Tang, Naping

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03269-8

6
Dysregulated immune microenvironment in metastatic colorectal cance

Author:An, Shuaixing; Yu, Zhaojin; Li, Jianping; Wei, Minjie

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-025-03112-6

7
Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophag

Author:Tang, Maoju; Gong, Feng; Yang, Miyuan; He, Shuang; Cheng, Jiao; Yang, Zhiheng; Xu, Lei; Ma, Qiang; Guo, Xiaolan; Zhong, Xiaowu

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03249-y

8
Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft mode

Author:Anayyat, Umer; Ye, Jianbin; Wu, Xumin; Liu, Zhiyu; Liao, Cui; Wang, Xiaomei; Liu, Muyun

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03271-0

9
A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K/AKT pathway to inhibit prostate cancer progressio

Author:Yang, Xianhui; Wang, Rui; Xu, Guangcan; Yang, Ziqi; Yao, Xingsheng; Liu, Guangyang; Yu, Jia; Xu, Bixue; Luo, Heng; Cao, Ying

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03256-z

10
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherap

Author:Chen, Shanshan; Zhang, Guangshun; He, Xiangyi; Li, Yuze; Li, Dong

Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-025-03232-z


在线咨询

Medical Oncology

国际简称:MED ONCOL参考译名:医学肿瘤学

年发文量:596 CiteScore:5.9 是否预警:否 Gold OA文章占比:14.25% 研究类文章占比:52.68%

杂志社联系方式:HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512

Medical Oncology